Long-term mortality outcomes and mortality predictors in patients with myelomeningocele
| dc.contributor.author | Deniz, Sahin Kenan | |
| dc.contributor.author | Turgut, Hatice | |
| dc.contributor.author | Deveci, Fatih | |
| dc.contributor.author | Kaya, Hueseyin | |
| dc.contributor.author | Gokce, Ismail Kursad | |
| dc.contributor.author | Ozdemir, Ramazan | |
| dc.contributor.author | Onal, Selami Cagatay | |
| dc.date.accessioned | 2026-04-04T13:35:11Z | |
| dc.date.available | 2026-04-04T13:35:11Z | |
| dc.date.issued | 2024 | |
| dc.department | İnönü Üniversitesi | |
| dc.description.abstract | Objective: Despite advances, myelomeningocele remains a major cause of mortality and disability. This study aims to analyze factors influencing mortality and suggest ways to reduce it. Methods: We reviewed 173 patients who underwent surgery for myelomeningocele from January 2010 to December 2021. Variables affecting mortality were categorized into patient-related and indirectly related factors. Data were collected through patient file reviews and phone interviews with parents. Results: Mortality is influenced by multiple factors: female gender (3.2-fold increase), paraplegia (3.1-fold increase), absence of tethered cord release surgery (9.4-fold increase), scoliosis (4.2-fold increase), and renal failure (5.28-fold increase). Defect size and father's education level also significantly impact mortality. The overall mortality rate was 20.8 %, with hydrocephalus being the leading cause. Conclusion: Mortality and disability in myelomeningocele patients remain high, with over 50 % of deaths being preventable. Effective management could significantly improve mortality rates. Long-term studies are crucial for advancing research in this field. | |
| dc.identifier.doi | 10.1016/j.clineuro.2024.108577 | |
| dc.identifier.issn | 0303-8467 | |
| dc.identifier.issn | 1872-6968 | |
| dc.identifier.orcid | 0000-0002-3328-4156 | |
| dc.identifier.orcid | 0000-0002-0490-7852 | |
| dc.identifier.orcid | 0000-0001-8952-2865 | |
| dc.identifier.orcid | 0000-0002-9177-6941 | |
| dc.identifier.orcid | 0000-0003-4722-1188 | |
| dc.identifier.pmid | 39383583 | |
| dc.identifier.scopus | 2-s2.0-85205693086 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.uri | https://doi.org/10.1016/j.clineuro.2024.108577 | |
| dc.identifier.uri | https://hdl.handle.net/11616/109676 | |
| dc.identifier.volume | 246 | |
| dc.identifier.wos | WOS:001332968200001 | |
| dc.identifier.wosquality | Q3 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Elsevier | |
| dc.relation.ispartof | Clinical Neurology and Neurosurgery | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WOS_20250329 | |
| dc.subject | Long-term outcome | |
| dc.subject | Mortality predictors | |
| dc.subject | Mortality rates | |
| dc.subject | Myelomeningocele | |
| dc.title | Long-term mortality outcomes and mortality predictors in patients with myelomeningocele | |
| dc.type | Article |











